20 results
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
#PrimaryCare #EM ... #IM #Differential ... Lightheadedness #Table #NEJM
Selective Publication of Antidepressant Trials

A more complete picture: contrasting the journal version of antidepressant trials with
//www.nejm.org/doi ... NEJMsa065779 #Policy #EBM ... Comparison #FDA #NEJM
PARAMEDIC2 Trial Visual Abstract: 
Adrenaline vs. Placebo in out-of-hospital
 - Tommaso Scquizzato
@tscquizzato

https://www.nejm.org/doi/full/10.1056/NEJMoa1806842
 A Randomized Trial of
//www.nejm.org/doi ... Cardiac Arrest #EBM ... #Prehospital #NEJM
Mortality after Fluid Bolus in African Children with Severe Infection - June 30, 2011 N Engl
//www.nejm.org/doi ... NEJMoa1101549 #EBM ... Boluses #Africa #NEJM
Major Clinical Trials and Evidence Summary for Transfusion Thresholds in Critical Care

TRICC - NEJM 1999 -
Care TRICC - NEJM ... 1999 - ICU FOCUS ... - NEJM 2011 - Hip ... UGIB TRISS - NEJM ... /vmoitra) #EBM
The HYPERION Trial - Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm - Visual Abstract

NEJM
Visual Abstract NEJM ... //www.nejm.org/doi ... VisualAbstract #EBM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - Incidence of New Vertebral, Clinical,
Nonvertebral Fracture #EBM ... PrimaryCare #Endo #IM ... #Alendronate #NEJM